Global Biotechnology Market is expected to grow with the CAGR of 27.9% in the forecast period of 2021 to 2028. The years considered for study are as mentioned below.

Access Full Report @ https://www.databridgemarketresearch.com/reports/global-biotechnology-market

Global biotechnology market is a highly consolidated market, which includes specific number of key players. The market has witnessed increased strategic developments owing to favourable market scenario.

The major players dealing in global biotechnology market are introducing strong range of products provider along with launching new products and adopting strategic initiative such as acquisition, agreement, business expansion, award and recognition into the market. This helped companies to maximize the sales with enhanced product portfolio.

For instance:

• In February 2021, Thermo Fisher Scientific Inc. has announced it has completed its previously announced acquisition of Mesa Biotech, Inc. This acquisition anticipated to strengthen company’s leadership in biotechnology market.

Thermo Fisher Scientific Inc. is the dominating player in global biotechnology market. The other key players existing in the market includes Trinity Biotech, Abbott, F. Hoffmann-La Roche Ltd, Charles River Laboratories, Eurofins Scientific, Promega Corporation, Bio-Rad Laboratories, Inc., PerkinElmer Inc., Takara Bio Inc., Ortho Clinical Diagnostics, QIAGEN, Agilent Technologies, Inc., AstraZeneca, Merck KGaA, bioMérieux SA, Myriad Genetics, Inc.,   Illumina, Inc.,  Pacific Biosciences of California, Inc. and Biogen among others.

Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc., founded in the year 1956 and is headquartered in Massachusetts, U.S. Company focuses on accelerating life sciences research, solving complex analytical challenges, improving patient diagnostics and therapies or increasing productivity in their laboratories. The company operates its business via several business segments including life sciences solutions, analytical instruments, specialty diagnostics and laboratory products and services in which life science solutions is the market focused segment. The company has product categories which are life sciences, industrial & applied science, clinical & diagnostics, lab solutions, digital solutions in which life sciences is the market focused category.

For instance,

• In September 2021, Thermo Fisher Scientific Inc. has launched the Applied Biosystems QuantStudio Absolute Q Digital PCR System, the first fully integrated digital PCR (dPCR) system designed to provide highly accurate and consistent results within 90 minutes. This product launch has created a persistence revenue-generating path for the company.

The company has presence across North America, Europe, Asia-Pacific, South America and Middle East Africa. The company also has various subsidiaries including Thermo Fisher Scientific Operating Company LLC (Delware, U.S), Thermo Fisher Scientific Senior Financing LLC (Delware, U.S), Thermo Fisher Scientific (DE) Holding S.a.r.l. (Luxemberg, Europe), Thermo Fisher Scientific Peru S.R.L. (Peru), Thermo Fisher Scientific Malaysia Sdn. Bhd. (Malaysia), Thermo Fisher Scientific (Barbados) Holding, Limited (Barbados), Fisher Clinical Services Japan K.K. (Japan), Fisher Clinical Services (Korea) Co., Ltd (Korea), Thermo Fisher Scientific Africa Proprietary Ltd (South Africa) and D-finitive Technologies, Inc. (South Carolina) among others.

F. Hoffmann-La Roche Ltd)

F. Hoffmann-La Roche Ltd. Is founded in 1896. F. Hoffmann-La Roche Ltd. And is headquartered is in Basel, Switzerland. Company is exclusively focusing on developing innovative medicines and diagnostic tests. The company operates its business via several business segments including Pharmaceuticals, Diagnostics in which Diagnostics is the market focused segment. The company has several product & service categories including Pharmaceuticals, Solutions for Diagnostics, Products for Researchers in which Solutions for Diagnostics is the market focused category.

For instance,

• In March 2017, F. Hoffmann-La Roche Ltd has launched the MagNA Pure 24 System for nucleic acid extraction and purification. The fully automated, magnetic bead-based clinical sample extractor features walk-away automation and provides on-board primary sample handling. This has enhanced revenue growth of the company.

The company has wide presence across Asia Pacific, Europe, Middle East and Africa, North America, South America. The company also has various subsidiary companies including Roche Holding Ltd. (Switzerland), Chugai Pharmaceutical Co., Ltd. (Japan), Roche Algérie SPA (Algeria), Roche Diabetes Care Australia Pty Limited (Australia) and Others.

AstraZeneca

AstraZeneca founded in the year 1999 and is headquartered in Cambridge, U.K. Company is focusing on science-led biopharmaceutical sector. The company has product categories which are R&D, Therapy Area in which R&D is the market focused category.

For instance,

• In September 2021, AstraZeneca Alexion has exercised its option to acquire all remaining equity in Caelum Biosciences. This acquisition anticipated enhance company growth pace.

The company has presence across North America, Europe, Asia-Pacific, Middle East and Africa. The company also has various subsidiaries including AstraZeneca UK Limited (England), AstraZeneca Treasury Limited (England), NV AstraZeneca SA (Belgium), AstraZeneca Dunkerque Production SCS (France) and Others.